Form 4 for PBYI PUMA BIOTECHNOLOGY, INC.
Accepted 2025-07-10 00:00:00 ET · period of report 2025-07-08 · accession 0001437749-25-022551 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-07-10 | 2025-07-08+ | PBYI | NOUGUES MAXIMO F | CFO | S - Sale | $3.53 | -9,522 | 204.2K | -4% | -$33.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-07-08 | S | D | 5,587 | $3.53 | 208,164 | D | — | — | |
| 2 | Common | Common Stock | 2025-07-09 | S | D | 3,935 | $3.54 | 204,229 | D | — | — |